drugset

drugset / Trial / NCT00160277

Efficacy and Safety of Moxonidine in Indian Patients

NCT00160277 ↗

Phase 3 Completed 100 enrolled Solvay Pharmaceuticals

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Timeline

Start: 2005-07
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Moxonidine	Small molecule	—	—

Indications